These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 170731)

  • 41. The treatment of Cushing's syndrome and adrenal cancer.
    Loriaux DL
    Endocrinol Metab Clin North Am; 1991 Dec; 20(4):767-71. PubMed ID: 1663867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. APPRAISAL OF ADRENOCORTICAL HYPERFUNCTION: PATIENTS WITH CUSHING'S SYNDROME OR "NON-ENDOCRINE" TUMORS.
    BROOKS RV; DUPRE J; GOGATE AN; MILLS IH; PRUNTY FT
    J Clin Endocrinol Metab; 1963 Aug; 23():725-36. PubMed ID: 14059549
    [No Abstract]   [Full Text] [Related]  

  • 43. Ectopic expression of serotonin7 receptors in an adrenocortical carcinoma co-secreting renin and cortisol.
    Louiset E; Isvi K; Gasc JM; Duparc C; Cauliez B; Laquerrière A; Kuhn JM; Lefebvre H
    Endocr Relat Cancer; 2008 Dec; 15(4):1025-34. PubMed ID: 18708508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [ACTH secretion and adrenocortical responsiveness in Cushing's syndrome due to adrenocortical hyperplasia (author's transl)].
    Suzuki S
    Nihon Naibunpi Gakkai Zasshi; 1976 Aug; 52(8):828-44. PubMed ID: 190054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cushing's syndrome].
    Shimizu N; Kato T
    Naika; 1971 Jun; 27(6):1202-6. PubMed ID: 4326410
    [No Abstract]   [Full Text] [Related]  

  • 46. Cushing's syndrome due to adrenal adenoma with persistent diurnal cortisol secretory rhythm.
    Olsen NJ; Fang VS; DeGroot LJ
    Metabolism; 1978 Jun; 27(6):695-700. PubMed ID: 206799
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dissociated recovery of cortisol and dehydroepiandrosterone sulphate after treatment for Cushing's syndrome.
    Kleiber H; Rey F; Temler E; Gomez F
    J Endocrinol Invest; 1991 Jun; 14(6):489-92. PubMed ID: 1663528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cushing's syndrome with pigmentation. (II)].
    Bricaire H; Luton JP; Laurent M
    Presse Med (1893); 1967 Dec; 75(55):2821-4. PubMed ID: 4296286
    [No Abstract]   [Full Text] [Related]  

  • 49. [A case of Cushing's syndrome due to bilateral multiple adrenal adenomas].
    Ashida S; Kataoka S; Yamasaki I; Yamashita M; Ohashi Y; Morioka M; Shuin T
    Hinyokika Kiyo; 1997 Aug; 43(8):567-70. PubMed ID: 9310779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia as a distinct subtype of Cushing's syndrome. Enzyme histochemical and ultrastructural study of four cases with a review of the literature.
    Aiba M; Hirayama A; Iri H; Ito Y; Fujimoto Y; Mabuchi G; Murai M; Tazaki H; Maruyama H; Saruta T
    Am J Clin Pathol; 1991 Sep; 96(3):334-40. PubMed ID: 1652202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surgical management of adrenocortical tumors with Cushing's syndrome.
    Scott HW; Foster JH; Rhamy RK; Klatte E; Liddle GW
    Ann Surg; 1971 Jun; 173(6):892-905. PubMed ID: 4325382
    [No Abstract]   [Full Text] [Related]  

  • 52. Plasma testosterone profiles in Cushing's syndrome.
    Smals AG; Kloppenborg PW; Benraad TJ
    J Clin Endocrinol Metab; 1977 Aug; 45(2):240-5. PubMed ID: 195973
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ACTH-producing pheochromocytoma.
    Berenyi MR; Singh G; Gloster ES; Davidson MI; Woldenberg DH
    Arch Pathol Lab Med; 1977 Jan; 101(1):31-5. PubMed ID: 188397
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Food-dependent Cushing's syndrome: characterization and functional role of gastric inhibitory polypeptide receptor in the adrenals of three patients.
    Lebrethon MC; Avallet O; Reznik Y; Archambeaud F; Combes J; Usdin TB; Narboni G; Mahoudeau J; Saez JM
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4514-9. PubMed ID: 9851802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour.
    Flecchia D; Mazza E; Carlini M; Blatto A; Olivieri F; Serra G; Camanni F; Messina M
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):129-34. PubMed ID: 7704956
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A phaeochromocytoma presenting with Cushing's syndrome associated with increased concentrations of circulating corticotrophin-releasing factor.
    Jessop DS; Cunnah D; Millar JG; Neville E; Coates P; Doniach I; Besser GM; Rees LH
    J Endocrinol; 1987 Apr; 113(1):133-8. PubMed ID: 3035046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ACTH-independent Cushing's syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures.
    Wei J; Li S; Liu Q; Zhu Y; Wu N; Tang Y; Li Q; Ren K; Zhang Q; Yu Y; An Z; Chen J; Li J
    BMC Endocr Disord; 2018 Apr; 18(1):22. PubMed ID: 29685132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unusual association of adrenal angiosarcoma and Cushing's disease.
    Invitti C; Pecori Giraldi F; Cavagnini F; Sonzogni A
    Horm Res; 2001; 56(3-4):124-9. PubMed ID: 11847475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CUSHING'S SYNDROME: NODULAR CORTICAL HYPERPLASIA OF ADRENAL GLANDS WITH CLINICAL AND PATHOLOGICAL FEATURES SUGGESTING ADRENOCORTICAL TUMOR.
    KIRSCHNER MA; POWELL RD; LIPSETT MB
    J Clin Endocrinol Metab; 1964 Oct; 24():947-55. PubMed ID: 14228534
    [No Abstract]   [Full Text] [Related]  

  • 60. Plasma immunoassayable ACTH levels during and after hydrocortisone infusion in patients with Cushing's disease.
    Hashimoto K; Takahara J; Hosogi H; Yunoki S; Ofuji T
    Endocrinol Jpn; 1976 Jun; 23(3):243-9. PubMed ID: 186258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.